ProEmpower has released a tender to procure a continuous disease self-management solution that will make person-centred care a reality.
Interested parties can access the tender here.
The ProEmpower procurers are looking for a diabetes management solution that will tackle the unmet needs in the current treatment of diabetes such as the fragmentation in today’s healthcare systems, the overreliance on and the ineffectiveness of pharmacotherapy, the late detection of the disease and the frequency of severe complications. This will be achieved by providing personalised and multi-disciplinary care to diabetes patients and empowering them to become responsible actors in the care process..The procured ProEmpower solution will address the need for the stratification of patients according to risk and promote the adoption of a team-based approach. Care will become person centred, guided by a personalised decision support system which will make it easier to set adequate treatment goals based on weighing in multiple factors. Self-management education will be a key component of the ProEmpower solution which will foster the creation of a peer support network for patients, in order to help them maintain a healthier lifestyle. At the same time, ProEmpower will contribute to creating a learning healthcare system based in a quality oriented culture that continuously improves itself.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions. Each selected operator will be awarded a framework agreement that covers three R&D phases. The three phases are: solution design, prototyping, original development, and validation and testing of a limited set of first products or services. After each phase, intermediate evaluations will be carried out to select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
Interested parties have until 21 March 2018 to submit a bid to vendors@proempower-pcp(dot)eu.
ProEmpower receives funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 727409